Cargando…

First-line therapy with LPV/r vs NVP and 2 NRTIs in a developing country: W144 of a randomized trial

Detalles Bibliográficos
Autores principales:	Clumeck, Nathan, Mwamba, Claude, Kabeya, Kabamba, Calvez, Vincent, Matanda, Serge, Vaira, Dolorès, Peytavin, Gilles, Necsoi, Coca, Delforge, Marc, Kadiebwe, David, Milolo, Chantal, Ilunga, Joe, Kapend, Liévin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220866/ http://dx.doi.org/10.1186/1471-2334-14-S2-O2

Ejemplares similares

First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting
por: Clumeck, Nathan, et al.
Publicado: (2014)

Profil épidémiologique et clinique de la tuberculose dans la zone de santé de Lubumbashi (RD Congo)
por: Ngama, Christian Kakisingi, et al.
Publicado: (2014)

Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study
por: Dauby, Nicolas, et al.
Publicado: (2011)

Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial
por: Clumeck, N, et al.
Publicado: (2010)

The clinical development of NRTIs — cautionary tales
por: Cooper, D
Publicado: (2010)

In Vitro and Ex Vivo Inhibition of Human Telomerase by Anti-HIV Nucleoside Reverse Transcriptase Inhibitors (NRTIs) but Not by Non-NRTIs
por: Hukezalie, Kyle R., et al.
Publicado: (2012)

Cardiovascular risk evaluation of HIV-positive patients in a case-control study: comparison of the D:A:D and Framingham equations
por: Markowicz, Samuel, et al.
Publicado: (2014)

CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily
por: Tiraboschi, Juan, et al.
Publicado: (2014)

Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
por: Deng, Lisi, et al.
Publicado: (2020)

Status of coupling compensation for the LPv3 optics in 1995
por: Verdier, A
Publicado: (1995)

144-week outcomes of lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: data from the German STAR/STELLA cohort
por: Wolf, Eva, et al.
Publicado: (2014)

The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes
por: Gray, Lachlan R., et al.
Publicado: (2013)

Multiscale Systems‐Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV‐1
por: Duwal, S, et al.
Publicado: (2016)

Outcomes related to 4864 pregnancies with exposure to lopinavir/ritonavir (LPV/r)
por: Tookey, Pat, et al.
Publicado: (2014)

A deterministic approach for design of supervisory control of LPV systems with delay
por: Zahid, Ch. Nauman, et al.
Publicado: (2021)

Self-Scheduled LPV Control of Asymmetric Variable-Span Morphing UAV
por: Lee, Jihoon, et al.
Publicado: (2023)

Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development
por: Ambati, Jayakrishna, et al.
Publicado: (2020)

LPV modeling of nonlinear systems: A multi‐path feedback linearization approach
por: Abbas, Hossam S., et al.
Publicado: (2021)

HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy
por: Martin, Allison, et al.
Publicado: (2013)

An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs
por: Smit, Erasmus, et al.
Publicado: (2017)

Nucleoside reverse transcriptase inhibitors (NRTIs) induce proinflammatory cytokines in the CNS via Wnt5a signaling
por: Wu, Ting, et al.
Publicado: (2017)

Bone Deleterious Effects of Different NRTIs in Treatment-naïve HIV Patients After 12 and 48 Weeks of Treatment
por: Atencio, Patricia, et al.
Publicado: (2021)

Limited HIV-1 Reactivation in Resting CD4(+) T cells from Aviremic Patients under Protease Inhibitors
por: Kumar, Amit, et al.
Publicado: (2016)

LPV Control for the Full Region Operation of a Wind Turbine Integrated with Synchronous Generator
por: Cao, Guoyan, et al.
Publicado: (2015)

Impact of a Mobile Application for Tracking Nausea and Vomiting During Pregnancy (NVP) on NVP Symptoms, Quality of Life, and Decisional Conflict Regarding NVP Treatments: MinSafeStart Randomized Controlled Trial
por: Ngo, Elin, et al.
Publicado: (2022)

Review of NVP and HG and Early Pharmacotherapeutic Intervention
por: Clark, Shannon M., et al.
Publicado: (2012)

Effectiveness of a reduced dose of efavirenz plus 2 NRTIs as maintenance antiretroviral therapy with the guidance of therapeutic drug monitoring
por: Yang, Shang-Ping, et al.
Publicado: (2014)

Authorship Correction: Impact of a Mobile Application for Tracking Nausea and Vomiting During Pregnancy (NVP) on NVP Symptoms, Quality of Life, and Decisional Conflict Regarding NVP Treatments: MinSafeStart Randomized Controlled Trial
por: Ngo, Elin, et al.
Publicado: (2022)

An LPV Adaptive Observer for Updating a Map Applied to an MAF Sensor in a Diesel Engine
por: Liu, Zhiyuan, et al.
Publicado: (2015)

Complex Crystal Structure Determination of Hsp90(N)-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922
por: He, Chun-Xia, et al.
Publicado: (2022)

NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017)

LPV Control and Virtual-Sensor-Based Fault Tolerant Strategies for a Three-Axis Gimbal System
por: Medero, Ariel, et al.
Publicado: (2022)

Beta and gamma ray studies of /sup 144/Cs, /sup 144/Ba and /sup 144 /La
por: Monnand, E, et al.
Publicado: (1976)

NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity
por: Fokas, Emmanouil, et al.
Publicado: (2012)

Analysis of major and minor IAS-USA PI mutations in the MONET trial of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs
por: Pulido, F, et al.
Publicado: (2010)

Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth
por: Padthaisong, Sureerat, et al.
Publicado: (2018)

Nausea and vomiting of pregnancy and resource implications: the NVP Impact Study
por: Gadsby, Roger, et al.
Publicado: (2019)

Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1
por: Maroldo, L, et al.
Publicado: (2010)

A new LPV modeling approach using PCA-based parameter set mapping to design a PSS
por: Jabali, Mohammad B. Abolhasani, et al.
Publicado: (2017)

Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: 96 weeks post VERITAS study
por: Trottier, Benoit, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_juggoq2shtute9fo2phld5ucgv